The mitochondrial component of intracrine action

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 299, Issue 3, 2010, Pages

  Re, Richard N ^a   Cook, Julia L ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Angiotensin II; Mitochondria; Transforming growth factor

Indexed keywords

ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; GROWTH HORMONE; HYPOCALCIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN; WNT 13 PROTEIN; WNT PROTEIN; SIGNAL PEPTIDE;

HUMAN; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM;

ANGIOTENSIN II; ANIMALS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOCHONDRIA; SIGNAL TRANSDUCTION;

EID: 77956687283     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00421.2010     Document Type: Review

References (79)

1. Ardail D, Debon A, Perret-Vivancos C, Biol-N'Garagba MC, Krantic S, Lobie PE, Morel G. Growth hormone internalization in mitochondria decreases respiratory chain activity. Neuroendocrinology 91: 16-26, 2010.
2. Azzu V, Jastroch M, Divakaruni AS, Brand MD. The regulation and turnover of mitochondrial uncoupling proteins. Biochim Biophys Acta 1797: 785-791, 2010.
3. Bellance N, Lestienne P, Rossignol R. Mitochondria: from bioenergetics to the metabolic regulation of carcinogenesis. Front Biosci 14: 4015-4034, 2009.
4. Cassis P, Conti S, Remuzzi G, Benigni A. Angiotensin receptors as determinants of life span. Pflügers Arch 459: 325-332, 2010.
5. Chen W, Jin W, Tian H, Sicurello P, Frank M, Orenstein JM, Wahl SM. Requirement for transforming growth factor beta1 in controlling T cell apoptosis. J Exp Med 194: 439-453, 2001.
6. Cho YW, Kim JD, Park K. Polycation gene delivery systems: escape from endosomes to cytosol. J Pharm Pharmacol 55: 721-734, 2003.
7. Cook JL, Re RN. Intracellular accumulation and nuclear trafficking of angiotensin. In: The Local Cardiac Renin-Angiotensin Aldosterone System (2nd ed.), edited by Frohlich ED and Re RN. New York: Springer, 2009, p. 29-41.
8. D'Alecy LG, Myers CL, Brewer M, Rising CL, Shlafer M. Substrate-specific stimulation by glucagon of isolated murine brain mitochondrial oxidative phosphorylation. Stroke 17: 305-312, 1986. (Pubitemid 16125257)
9. de Cavanagh EM, Ferder M, Inserra F, Ferder L. Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint. Am J Physiol Heart Circ Physiol 296: H550-H558, 2009.
10. 1 blockade in experimental Type I diabetes. Am J Physiol Heart Circ Physiol 294: H456-H465, 2008.
11. de Cavanagh EM, Inserra F, Ferder M, Ferder L. From mitochondria to disease: role of the renin-angiotensin system. Am J Nephrol 27: 545-553, 2007.
12. De Cavanagh EM, Toblli JE, Ferder L, Piotrkowski B, Stella I, Fraga CG, Inserra F. Angiotensin II blockade improves mitochondrial function in spontaneously hypertensive rats. Cell Mol Biol (Noisy-le-grand) 51: 573-578, 2005.
13. Dikalova AE, Bikineyeva AT, Budzyn K, Nazarewicz RR, McCann L, Lewis W, Harrison DG, Dikalov SI. Therapeutic targeting of mitochondrial superoxide in hypertension. Circ Res 107: 106-116, 2010.
14. Doughan AK, Harrison DG, Dikalov SI. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 102: 488-496, 2008.
15. Echave P, Machado-da-Silva G, Arkell RS, Duchen MR, Jacobson J, Mitter R, Lloyd AC. Extracellular growth factors and mitogens cooperate to drive mitochondrial biogenesis. J Cell Sci 122: 4516-4525, 2009.
16. Emre Y, Nübel T. Uncoupling protein UCP2: when mitochondrial activity meets immunity. FEBS Lett 584: 1437-1442, 2010.
17. Erdmann B, Fuxe K, Ganten D. Subcellular localization of angiotensin II immunoreactivity in the rat cerebellar cortex. Hypertension 28: 818-824, 1996. (Pubitemid 26365524)
18. Fehrenbach H, Kasper M, Haase M, Schuh D, Müller M. Differential immunolocalization of VEGF in rat and human adult lung, and in experimental rat lung fibrosis: light, fluorescence, and electron microscopy. Anat Rec 254: 61-73, 1999.
19. Fukai T. Mitochondrial thioredoxin: novel regulator for NADPH oxidase and angiotensin II-induced hypertension. Hypertension 54: 224-225, 2009.
20. Gasdaska PY, Oblong JE, Cotgreave IA, Powis G. The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): thioredoxin mRNA is elevated in some human tumors. Biochim Biophys Acta 1218: 292-296, 1994.
21. Goodfriend TL, Fyhrquist F, Gutmann F, Knych E, Hollemans H, Allmann D, Kent K, Cooper T. Clinical and conceptual uses of angiotensin receptors. In: Hypertension' 72, edited by Genest J and Koiw E. Berlin: Springer-Verlag, 1972, p. 549-563.
22. Gwathmey TM, Pendergrass KD, Reid SD, Rose JC, Diz DI, Chappell MC. Angiotensin-(1-7)-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus. Hypertension 55: 166-171, 2010.
23. 2) receptors are functionally linked to nitric oxide production. Am J Physiol Renal Physiol 296: F1484-F1493, 2009.
24. Heine UI, Burmester JK, Flanders KC, Danielpour D, Munoz EF, Roberts AB, Sporn MB. Localization of transforming growth factor-beta 1 in mitochondria of murine heart and liver. Cell Regul 2: 467-477, 1991.
25. Heisler S. Direct binding of atrial natriuretic factor to adrenocortical mitochondria. Eur J Pharmacol 162: 281-288, 1989.
26. Hoosein NM, Gurd RS. Identification of glucagon receptors in rat brain. Proc Natl Acad Sci USA 81: 4368-4372, 1984. (Pubitemid 14052446)
27. Jaferi A, Lane DA, Pickel VM. Subcellular plasticity of the corticotrop-in- releasing factor receptor in dendrites of the mouse bed nucleus of the stria terminalis following chronic opiate exposure. Neuroscience 163: 143-154, 2009.
28. Kim HJ, Lee HJ, Jun JI, Oh Y, Choi SG, Kim H, Chung CW, Kim IK, Park IS, Chae HJ, Kim HR, Jung YK. Intracellular cleavage of osteopontin by caspase-8 modulates hypoxia/reoxygenation cell death through p53. Proc Natl Acad Sci USA 106: 15326-15331, 2009.
29. Kohashi N, Trippodo NC, MacPhee AA, Frohlich ED, Cole FE. Rat atrial natriuretic peptides inhibit oxygen consumption by rat kidney. Hypertension 7: 491-498, 1985.
30. Kondoh H. Cellular life span and the Warburg effect. Exp Cell Res 314: 1923-1928, 2008.
31. Lee TH, Seng S, Sekine M, Hinton C, Fu Y, Avraham HK, Avraham S. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/ FLT1. PLoS Med 4: e186, 2007.
32. 1a receptors. Am J Physiol Cell Physiol 294: C1034-C1045, 2008.
33. Lopez-Campistrous A, Hao L, Xiang W, Ton D, Semchuk P, Sander J, Ellison MJ, Fernandez-Patron C. Mitochondrial dysfunction in the hypertensive rat brain: respiratory complexes exhibit assembly defects in hypertension. Hypertension 51: 412-419, 2008.
34. Luo S, Shaw WM, Ashraf J, Murphy CT. TGF-beta Sma/Mab signaling mutations uncouple reproductive aging from somatic aging. PLoS Genet 5: e1000789, 2009.
35. Mitsuishi M, Miyashita K, Muraki A, Itoh H. Angiotensin II reduces mitochondrial content in skeletal muscle and affects glycemic control. Diabetes 58: 710-717, 2009.
36. Morel G, Chabot JG, Garcia-Caballero T, Gossard F, Dihl F, Belles-Isles M, Heisler S. Synthesis, internalization, and localization of atrial natriuretic peptide in rat adrenal medulla. Endocrinology 123: 149-158, 1988.
37. Morel G, Mesguich P, Chabot JG, Belles-Isles M, Jeandel L, Heisler S. Internalization of atrial natriuretic peptide by adrenal glomerulosa cells. Biol Cell 65: 181-188, 1989. (Pubitemid 19120666)
38. Mortensen M, Ferguson DJ, Edelmann M, Kessler B, Morten KJ, Komatsu M, Simon AK. Loss of autophagy in erythroid cells leads to defective removal of mitochondria and severe anemia in vivo. Proc Natl Acad Sci USA 107: 832-837, 2010.
39. Nakamura H. Thioredoxin and its related molecules: update 2005. Antioxid Redox Signal 7: 823-828, 2005.
40. Nonn L, Williams RR, Erickson RP, Powis G. The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol Cell Biol 23: 916-922, 2003.
41. 1 receptor stimulates reactive oxygen species within the cell nucleus. Biochem Biophys Res Commun 384: 149-154, 2009.
42. Peters J, Kränzlin B, Schaeffer S, Zimmer J, Resch S, Bachmann S, Gretz N, Hackenthal E. Presence of renin within intramitochondrial dense bodies of the rat adrenal cortex. Am J Physiol Endocrinol Metab 271: E439-E450, 1996. (Pubitemid 126757537)
43. Powis G, Oblong JE, Gasdaska PY, Berggren M, Hill SR, Kirkpatrick DL. The thioredoxin/thioredoxin reductase redox system and control of cell growth. Oncol Res 6: 539-544, 1994.
44. Re RN. Cardiac angiotensin II: an intracrine hormone? Am J Hypertens 16: 426-427, 2003.
45. Re RN. The implications of intracrine hormone action for physiology and medicine. Am J Physiol Heart Circ Physiol 284: H751-H757, 2003.
46. Re RN. The intracellular renin angiotensin system: the tip of the intracrine physiology iceberg. Am J Physiol Heart Circ Physiol 293: H905-H906, 2007.
47. Re RN. Intrancellular renin and the nature of intracrine enzymes. Hypertension 42: 117-122, 2003.
48. Re RN. The intracrine hypothesis and intracellular peptide hormone action. Bioessays 25: 401-409, 2003.
49. Re RN. The nature of intracrine peptide hormone action. Hypertension 34: 534-538, 1999.
50. Re RN. The origins of intracrine hormone action. Am J Med Sci 323: 43-48, 2002.
51. Re RN. A proposal regarding the biology of memory: participation of intracrine peptide networks. Med Hypotheses 63: 887-894, 2004.
52. Re RN. Toward a theory of intracrine hormone action. Regul Pept 106: 1-6, 2002. (Pubitemid 34607330)
53. Re RN, Bryan SE. Functional intracellular renin-angiotensin systems may exist in multiple tissues. Clin Exp Hypertens A 6: 1739-1742, 1984.
54. Re RN, Cook JL. The basis of an intracrine pharmacology. J Clin Pharmacol 48: 344-350, 2008.
55. Re RN, Cook JL. The intracrine hypothesis: an update. Regul Pept 133: 1-9, 2006.
56. Re RN, Cook JL. Mechanisms of disease: intracrine physiology in the cardiovascular system. Nat Clin Pract Cardiovasc Med 4: 549-557, 2007.
57. Re RN, Cook JL. An intracrine view of angiogenesis. Bioessays 28: 943-953, 2006.
58. Re RN, Cook JL. The physiological basis of intracrine stem cell regulation. Am J Physiol Heart Circ Physiol 295: H447-H453, 2008.
59. Re RN, Cook JL. Potential therapeutic implications of intracrine angiogenesis. Med Hypotheses 69: 414-421, 2007.
60. Re RN, Cook JL. Senescence, apoptosis, and stem cell biology: the rationale for an expanded view of intracrine action. Am J Physiol Heart Circ Physiol 297: H893-H901, 2009.
61. Re RN, MacPhee AA, Fallon JT. Specific nuclear binding of angiotensin II. Clin Sci (Lond) 61: 245s-247s, 1981.
62. Redding KM, Chen BL, Singh A, Re RN, Navar LG, Seth DM, Sigmund CD, Tang WW, Cook JL. Transgenic mice expressing an intracellular fluorescent fusion of angiotensin II demonstrate renal thrombotic microangiopathy and elevated blood pressure. Am J Physiol Heart Circ Physiol 298: H1807-H1818, 2010.
63. Robertson AL, Khairallah PA. Angiotensin II: rapid localization in nuclei of smooth and cardiac muscle. Science 172: 1138-1139, 1971.
64. Roth-Eichhorn S, Kühl K, Gressner AM. Subcellular localization of (latent) transforming growth factor beta and the latent TGF-beta binding protein in rat hepatocytes and hepatic stellate cells. Hepatology 28: 1588-1596, 1998. (Pubitemid 28549129)
65. Sazonova O, James KA, McCudden CR, Segal D, Talebian A, Wagner GF. Stanniocalcin-1 secretion and receptor regulation in kidney cells. Am J Physiol Renal Physiol 294: F788-F794, 2008.
66. Sheikh-Hamad D. Mammalian stanniocalcin-1 activates mitochondrial antioxidant pathways: new paradigms for regulation of macrophages and endothelium. Am J Physiol Renal Physiol 298: F248-F254, 2010.
67. Short KR, Moller N, Bigelow ML, Coenen-Schimke J, Nair KS. Enhancement of muscle mitochondrial function by growth hormone. J Clin Endocrinol Metab 93: 597-604, 2008.
68. Singh R, Choubey D, Chen J, Leehey DJ. Inhibition of intracellular angiotensin II formation blocks high glucose effect on mesangial matrix. Regul Pept 158: 103-109, 2009.
69. Strange J, Roberts RA. Reduced expression of mature TGF beta 1 correlates with the suppression of rat hepatocyte apoptosis by the peroxisome proliferator, nafenopin. Mutat Res 372: 107-113, 1996. (Pubitemid 27026533)
70. Struewing IT, Toborek A, Mao CD. Mitochondrial and nuclear forms of Wnt13 are generated via alternative promoters, alternative RNA splicing, and alternative translation start sites. J Biol Chem 281: 7282-7893, 2006.
71. Sumbalova Z, Kucharska J, Kristek F. Losartan improved respiratory function and coenzyme Q content in brain mitochondria of young spontaneously hypertensive rats. Cell Mol Neurobiol 30: 751-758, 2010.
72. Tanaka T, Hosoi F, Yamaguchi-Iwai Y, Nakamura H, Masutani H, Ueda S, Nishiyama A, Takeda S, Wada H, Spyrou G, Yodoi J. Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J 21: 1695-1703, 2002. (Pubitemid 34614625)
73. Tormos KV, Chandel NS. Inter-connection between mitochondria and HIFs. J Cell Mol Med 14: 795-804, 2010.
74. Williams AO, Knapton AD, Geiser A, Letterio JJ, Roberts AB. The liver in transforming growth factor-Beta-1 (TGF-beta 1) null mutant mice. Ultrastruct Pathol 20: 477-490, 1996. (Pubitemid 26319675)
75. Yogev O, Yogev O, Singer E, Shaulian E, Goldberg M, Fox TD, Pines O. Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response. PLoS Biol 8: e1000328, 2010.
76. Yoon YS, Lee JH, Hwang SC, Choi KS, Yoon G. TGF beta1 induces prolonged mitochondrial ROS generation through decreased complex IV activity with senescent arrest in Mv1Lu cells. Oncogene 24: 1895-1903, 2005.
77. Zhang K, Lindsberg PJ, Tatlisumak T, Kaste M, Olsen HS, Andersson LC. Stanniocalcin: a molecular guard of neurons during cerebral ischemia. Proc Natl Acad Sci USA 97: 3637-3642, 2000. (Pubitemid 30183355)
78. Zheng Z, Chen H, Ke G, Fan Y, Zou H, Sun X, Gu Q, Xu X, Ho PC. Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondria-reactive oxygen species pathway. Diabetes 58: 954-964, 2009.
79. Ziviani E, Tao RN, Whitworth AJ. Drosophila Parkin requires PINK1 for mitochondrial translocation and ubiquitinates Mitofusin. Proc Natl Acad Sci USA 107: 5018-5023, 2010.